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GABAergic interneurons are essential for a functional equilibrium between excitatory
and inhibitory impulses throughout the CNS. Disruption of this equilibrium can lead
to various neurological or neuropsychiatric disorders such as epilepsy or schizophrenia.
Schizophrenia itself is clinically defined by negative (e.g., depression) and positive (e.g.,
hallucinations) symptoms as well as cognitive dysfunction. GABAergic interneurons are
proposed to play a central role in the etiology and progression of schizophrenia; however,
the specific mechanisms and the time-line of symptom development as well as the
distinct involvement of cortical and hippocampal GABAergic interneurons in the etiology
of schizophrenia-related symptoms are still not conclusively resolved. Previous work
demonstrated that GABAergic interneurons can be selectively depleted in adult mice by
means of saporin-conjugated anti-vesicular GABA transporter antibodies (SAVAs) in vitro
and in vivo. Given their involvement in schizophrenia-related disease etiology, we ablated
GABAergic interneurons in the medial prefrontal cortex (mPFC) and dorsal hippocampus
(dHPC) in adult male C57BL/6N mice. Subsequently we assessed alterations in anxiety,
sensory processing, hyperactivity and cognition after long-term (>14 days) and short-term
(<14 days) GABAergic depletion. Long-term GABAergic depletion in the mPFC resulted in a
decrease in sensorimotor-gating and impairments in cognitive flexibility. Notably, the same
treatment at the level of the dHPC completely abolished spatial learning capabilities. Short-
term GABAergic depletion in the dHPC revealed a transient hyperactive phenotype as well
as marked impairments regarding the acquisition of a spatial memory. In contrast, recall
of a spatial memory was not affected by the same intervention. These findings emphasize
the importance of functional local GABAergic networks for the encoding but not the recall
of hippocampus-dependent spatial memories.
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INTRODUCTION
GABAergic interneurons mediate several key features throughout
the central nervous system. They are important for the equilib-
rium between excitatory and inhibitory inputs, which in turn is
necessary for a functioning neuronal network (Markram et al.,
2004; Kullmann et al., 2012). Although GABAergic interneurons
represent only about one fifth of cortical neurons and even less
in the dorsal hippocampus (dHPC; Jinno and Kosaka, 2010;
Lehmann et al., 2012), a disturbance of GABAergic development
or the GABAergic network quickly leads to detrimental conse-
quences as seen in neurological and neuropsychiatric disorders,
such as epilepsy, depression or schizophrenia (Sanacora et al.,
2000; Wong et al., 2003; Hossein Fatemi et al., 2005; Inan et al.,
2013; Gilani et al., 2014).
The GABA hypothesis of schizophrenia often implicates the
frontal cortex as one of the key players in the disease etiology
and progression (Blum and Mann, 2002). Clinically, schizophre-
nia is characterized by positive symptoms (e.g., hallucinations
or movement disorders), negative symptoms (e.g., anhedonia)
and cognitive dysfunction (e.g., deficits in working memory),
which also involves the hippocampal structure (Tamminga and
Holcomb, 2005; Powell and Geyer, 2007). Especially the posi-
tive symptoms are difficult to mimic in animal models; there-
fore, a distinction is used for endophenotypes with little face
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validity but high predictive validity (e.g., hyperlocomotion) or
endophenotypes with face-, construct- and predictive validity,
such as altered sensorimotor gating (Swerdlow and Geyer, 1998;
Powell and Geyer, 2007).
There are several subclasses of GABAergic interneurons, which
can be distinguished based on their morphology, their expres-
sion of calcium-binding proteins (e.g., parvalbumin, calbindin
or calretinin), the co-expression of neuropeptides (e.g., somato-
statin or vasointestinal peptide) and electrophysiological proper-
ties (Freund and Buzsáki, 1996; Markram et al., 2004; Kubota,
2014). Each of these subclasses has been linked to particular func-
tions and/or distributions throughout the forebrain (Markram
et al., 2004; Kubota, 2014). However, Parvalbumin-positive (PV+)
interneurons, representing one of the largest GABAergic sub-
classes, have been especially implicated in learning and memory
related neuronal plasticity (Caillard et al., 2000; Donato et al.,
2013; Bissonette et al., 2014).
Cognitive tasks such as spatial memory acquisition and
the recall of a spatial memory crucially depend on an intact
hippocampal formation (Morris, 1984; Nakazawa et al.,
2004; Schlesiger et al., 2013). Particularly the feed-forward
inhibition via fast spiking interneurons in the CA3 region of the
hippocampal formation has been shown to be intricately involved
in the precise acquisition of a spatial or contextual memory
(Ruediger et al., 2011). In contrast, reversal learning of spatial
memories (i.e., cognitive flexibility) additionally relies on the
prefrontal cortex (PFC; Euston et al., 2012; Ashwell and Ito, 2014;
Baker and Ragozzino, 2014).
However, the hippocampus (HPC) and the PFC are not only
integral for cognitive abilities in mice as well as men, but both
have also been implicated in schizophrenia-related symptom
development, where, in turn, cognitive deficits are recognized as
a prominent symptom of the disease (Kuperberg and Heckers,
2000; Lewis, 2000; Blum and Mann, 2002; Sesack and Carr, 2002;
Sweatt, 2004; Ross et al., 2006; Waltz and Gold, 2007; Euston
et al., 2012; Ibrahim and Tamminga, 2012; Nakazawa et al., 2012;
Savanthrapadian et al., 2013; Bissonette et al., 2014).
There are a number of techniques available to selectively
inactivate and/or deplete GABAergic interneurons in order to
study their effects on exploratory and cognitive behavior and their
involvement in schizophrenia-related symptoms. While the opto-
genetic tool box offers very elegant and sophisticated approaches
to discern a specific local neuronal circuit (Fenno et al., 2011;
Madisen et al., 2012; Buetfering et al., 2014), here, we aimed
to investigate the consequences of chronic GABAergic cell loss
and thus a global dysfunction in the PFC and the dHPC. We
employed the local administration of targeted saporin-conjugated
anti-vesicular GABA transporter antibodies (SAVAs; Antonucci
et al., 2012). SAVAs are directed against the intravesicular epitopes
of the vesicular GABA transporter (VGAT). Upon fusion of the
vesicles with the presynaptic membrane, these epitopes become
accessible to the extracellular milieu and thereby to the conjugated
antibodies (Martens et al., 2008). Subsequent recycling of the
vesicles leads to internalization of the SAVAs, which then accu-
mulate in GABAergic nerve terminals and ultimately lead to the
destruction of GABAergic neurons due to saporin toxicity, i.e.,
ribosome inactivation (Wiley, 1992; Antonucci et al., 2012). We
chose this technique in order to investigate the behavioral effects
of GABAergic ablation over time in a region-specific manner
by targeting either the prelimbic cortex (PrL) or the dHPC.
We hypothesized that this rather broad network manipulation
will resemble a pathological-like neuronal functional allostasis
(McEwen, 2000) and thus reveal new insight into the pathology-
related symptom development following the degeneration of
GABAergic neurons. With respect to the temporal dynamics of
neuropathological changes following SAVA treatment (Antonucci
et al., 2012), we assessed behavioral consequences of SAVA at early
(<10 days) vs. late time points (>14 days) after administration.
We focused our analyses on positive symptoms (i.e., development
of hyperactivity and deficits in pre-pulse inhibition (PPI) of the
startle response) and cognitive impairments. More specifically,
schizophrenia-related hyperactivity-like behavior was assessed
via an open field (OF) test under red-light conditions (Jacob
et al., 2009). Altered sensorimotor gating responses were assessed
by presenting varying minor acoustic noise bursts at different
intervals before the main acoustic startle impulse was presented
in an acoustic startle response (ASR) protocol (Golub et al.,
2009). Cognitive impairments after GABAergic depletion were
investigated using a contextual fear conditioning (FC) paradigm
and/or a spatial learning paradigm in a modified water maze
task (Kleinknecht et al., 2012). Although negative symptoms such
as alterations in social behavior are a common finding among
schizophrenic patients (Girardi et al., 2014), given the relatively
short time frame between selective GABAergic depletion and
secondary glutamatergic neuronal loss (Antonucci et al., 2012)
and the limited involvement of GABAergic neurons of the PFC
in social interaction (Yizhar et al., 2011), we decided to forego
social behavior-related testing and focused on hyperactivity,
sensorimotor gating and cognitive consequences of GABAergic
depletion.
We investigated the effects of GABAergic ablation in two
different brain structures and for varying incubation periods after
SAVA administration: >14 days of incubation after SAVA applica-
tion were used to study long-term effects of GABAergic depletion
in the PrL and dHPC, and <10 days were chosen to track short-
term consequences of GABAergic interneuron depletion in the
dHPC of C57BL/6N mice. In addition, we confirmed that the
dHPC is involved not only in the acquisition, but also the recall of
spatial memory, by local infusion of the GABAA agonist Muscimol
into the dHPC.
MATERIALS AND METHODS
All experimental procedures were approved by the Committee on
Animal Health and Welfare of the State of Bavaria (Regierung
von Oberbayern, Munich, Germany, AZ 55.2-1-54-2532-142-
12) and were performed in compliance with the European
Economic Community (EEC) recommendations for the care
and use of laboratory animals (2010/63/EU). Every effort was
done to minimize animal suffering and to reduce the necessary
sample sizes.
SAVA
SAVAs have been prepared as previously described (Antonucci
et al., 2012). Briefly, 1 mg reduced rabbit anti-VGAT-C
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(131103, Synaptic Systems, Göttingen, Germany) was coupled
to 2 mg of saporin (Sigma-Aldrich, Taufkirchen, Germany)
with the bifunctional cross-linker sulfosuccinimidyl 6-
[α-methyl-α-(pyridyldithio) toluamido]hexanoate (sulfo-
LC-SMPT, Thermo Fisher Scientific, Schwerte, Germany). Free
saporin was removed by affinity purification of SAVA using
VGAT-C immunogen immobilized on sulfolink coupling resin
(Thermo Fisher Scientific).
ANIMALS
In this study a total of 109 male C57BL/6N mice from the Max
Planck Institute breeding facility in Martinsried, Germany, were
used. Mice were approximately 10 weeks of age at delivery and
were allowed to acclimatize to the new surrounding for 10 days
before surgery. After surgery animals were housed individually in
type II standard Makrolon cages in a 12 h : 12 h inverse light/ dark
cycle (lights off 9 a.m.) in a temperature and humidity controlled
room with access to food and water ad libitum. All behavioral
testing was performed during the dark phase between 9 a.m.
and 9 p.m.
EXPERIMENTAL SCHEDULES
We investigated the effects of SAVA-induced GABAergic lesions in
four different experiments: Experiment (I) to Experiment (IV)
and performed one additional control experiment (Experiment
(V)) to assess the general involvement of the dHPC in spatial
memory recall.
In Experiment (I) we targeted the PrL bilaterally at lateral (l)
0.5 (from midline); anterior-posterior (a-p) +1.9 (from Bregma);
ventral (v) 2.5 mm (from the surface of the skull) with a volume
of 0.5 µl each side. Ten mice were injected with phosphate-
buffered saline (PBS) and 10 mice with SAVAs. Both groups were
allowed to recover from surgery for 14 days before behavioral
testing. On days 15 to 21 after surgery, mice underwent basal
phenotyping in the OF, Dark-Light box (D-L box) and ASR test,
the latter both for direct Input-Output (I/O) measurements
as well as Pre-Pulse Inhibition/Facilitation (PPI/PPF). On
days 22 to 36 after surgery, mice underwent cognitive test-
ing in the Water-Cross Maze (WCM) and FC. On day
37 after surgery, mice were perfused transcardially with 4%
PFA − PBS + 0.1% glutaraldehyde, and the fixed brains were
harvested for histological processing.
With Experiment (II) we targeted the dHPC by bilateral
injections at l 1.3; a-p −1.8; v 2.0 mm with a volume of 2 µl each
side. We injected 8 mice with PBS, 8 mice with un-conjugated
SAVAs (i.e., anti-vesicular GABA transporter antibodies without
saporin; ucAB) and 8 mice with SAVAs (SAVA). All three
groups were allowed to recover from surgery for 14 days before
behavioral testing. Behavioral testing and final brain harvesting
were done in parallel to Experiment (I).
Experiment (III) investigated the short-term effects of
SAVA injection in the dHPC on spatial memory acquisition.
We implanted guide cannulas bilaterally at l 1.3; a-p −1.8; v 1.0
mm, allowed the animals to recover for 12 days and only then
injected 0.5 µl of either PBS (n = 13) or SAVA (n = 13) per
cannula. On day 2 post injection (pi) animals underwent testing
in the OF, and on day 3 to 9 pi animals were trained in the
WCM before being tested in the OF once more on day 10 pi.
Animals were transcardially perfused and brains harvested on
day 11 pi.
Experiment (IV) investigated the short-term effects of SAVA
injection in the dHPC on spatial memory recall. We implanted
cannulas as described for Experiment (III), and allowed the
animals to recover for 12 days. Afterwards mice were tested in
the OF on day 13, trained in the WCM on day 14–day 20 fol-
lowed by intra-hippocampal injections with 0.5 µl of either PBS
(n = 10) or SAVA (n = 14) on day 21 post cannula implantation
(= d0 pi). On day 2 and 8 pi mice were tested in the OF whereas
on day 3 + 4 pi and day 9 + 10 pi spatial memory recall in the
WCM was examined. Animals were transcardially perfused and
brains recovered on day 11 pi.
Experiment (V): Muscimol–Control: In order to determine
whether the dHPC was involved in the recall of a spatial memory
at all, we implanted guide cannulas for a new cohort of mice as
described for Experiment (III), allowed the animals to recover
for 12 days and then trained them in the WCM for 7 days until
all mice had successfully learned the platform position. Two days
later, we injected 0.125 µg muscimol dissolved in 0.5 µl saline
into each hemisphere. This dose corresponds to the dosages used
in the literature (Allen et al., 2008; Biedenkapp and Rudy, 2009;
McEown and Treit, 2010; Oliveira et al., 2010; Stackman et al.,
2012).
Ten minutes after the injection mice were again placed in the
WCM and recall of spatial memory was assessed for six trials per
animal. As a treatment control we employed a “within-subject
design”, i.e., 24 h after the MSC test, mice were injected with PBS
and again tested in the WCM for 6 trials.
OPEN FIELD
OF testing was performed under red-light conditions in order
to observe pure locomotor effects rather than anxiety-related
behavior (Carola et al., 2002). OF testing was performed as
described previously (Jacob et al., 2009; Yen et al., 2013). Briefly,
animals were placed in an OF box (26 × 26 × 38 cm, Coulbourn
Instruments, Allentown, PA, USA) and allowed to explore freely
for 30 min.
The floor of the box was surrounded by two infrared sensor
rings in order to record horizontal and vertical movements. The
infrared sensors were located 2 and 5 cm above the floor, spaced
apart by 1.52 cm and connected to a computer running the
Tru Scan Software Version 1.1 (Coulbourn Instruments) with
a sampling rate of 4 Hz. Each OF box, was surrounded by an
additional box made of opaque Plexiglas side walls (47 × 47 ×
38 cm).
After testing, mice were returned to their home cages, and
the OF boxes and floor planes were carefully cleaned with water
and dried. If only the lower infrared beams recorded beam-brakes
(all four paws on the floor), the program scored this as horizontal
movement/rest, if both lower and upper rows of infrared beams
recorded beam-brakes, this was scored as vertical movement
(e.g., rearing), if only the upper row of beams recorded beam-
brakes it was scored as jumping. Total horizontal movement
(i.e., distance), frequency of vertical movements (i.e., rearing) and
duration of vertical movements were later analyzed in 5 min bins.
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DARK-LIGHT BOX
D-L Box testing was performed as previously described (Jacob
et al., 2009).
Briefly, D-L consisted of a dark compartment (15 × 20 ×
25 cm) and an illuminated (600 lux) compartment (30 × 20 ×
25 cm), which were connected by a 4 cm-long tunnel. Duration
of testing was 5 min per animal, at the beginning of which each
animal was placed in the dark compartment. The entire box
was thoroughly cleaned between animals with water contain-
ing detergent and dried before placing the next animal inside.
After testing, latency to enter the light compartment, frequency
to enter the light compartment and relative time (duration) spent
in the light compartments were scored by a trained observer blind
to the animals’ treatment by means of the EVENTLOG software
(designed by Robert Henderson in 1986).
ACOUSTIC STARTLE RESPONSE
ASR was assessed as previously described (Golub et al., 2009).
In brief, mice were placed in a non-restrictive Plexiglas cylin-
der which was mounted onto a plastic platform located in a
sound attenuated chamber (SR-LAB, San Diego Instruments,
San Diego, CA, USA). This set-up quantifies changes in the
conductance as a response to varying acoustic stimuli. These
changes in conductance were detected by a piezoelectric sensor
located underneath each cylinder. The startle amplitude was
defined as the peak voltage output within the first 50 ms after
stimulus onset. The startle stimuli itself consisted of 20 ms
white noise bursts at 75, 90, 105 and 115 dB SPL against
a constant background noise of 50 dB SPL and the startle
response Input/Output curve was assessed via a protocol con-
sisting of 136 pseudo-randomized trials of aforementioned white
noise bursts. All cylinders were thoroughly cleaned with water
containing detergent between animals. Mean startle amplitude
per stimulus intensity was later analyzed in an Input/Output
curve.
PPI/PPF was assessed within the same set-up as the ASR,
but with a different protocol. During this protocol animals were
presented with a brief pre- pulse white noise burst of 55, 65 or 75
dB SPL intensity at varying Inter Pulse Intervals (IPI) of either
5, 10, 25, 50 or 100 ms before the acoustic stimulus, a 50 ms
white noise burst of 115 dB SPL. This protocol consisted of 270
pseudo-randomized trials and mean startle amplitude per pre-
pulse intensity was calculated by subtracting the startle amplitude
at the 115 dB test pulse from the startle amplitude after pre-
pulse presentation, and dividing this by the startle amplitude at
115 dB× 100.
FEAR CONDITIONING
FC was performed as previously described (Kamprath and
Wotjak, 2004). In brief, mice were placed in conditioning cham-
bers (ENV-307A, Med Associates Inc., St. Albans, VT, USA) with
elongated Plexiglas walls and a grid floor for shock application.
The grid floor was placed above bedding identical to the home
cage bedding. The conditioning context was thoroughly cleaned
and sprayed with 70% ethanol (EtOH) before placing each mouse
inside. On day 0 of the FC protocol mice were placed in the
conditioning context and left to explore it for 3 min under house
light (0.6 Lux) conditions. After these 3 min a 20 s tone (9 kHz
at 80 dB SPL) was presented, the last 2 s of which co-terminated
with a 0.7 mA foot shock. After shock application mice remained
in the conditioning context for an additional 60 s without tone
presentation before being placed back to their home cage. The
conditioning context and the novel context were additionally
placed in separate sound attenuating isolation boxes. CCD cam-
eras inside each isolation box allowed for behavioral scoring after
testing.
On day 1 a.m. mice were placed back in the conditioning
context for 3 min under house light conditions without tone
or shock presentations. On day 1 p.m. mice were placed in
a novel context with different contextual features (e.g., Cylin-
der instead of cubicle, bedding without grid, 1% acetic acid
(CH3COOH) instead of EtOH) under house light conditions for
3 min without tone presentation followed directly by a 3 min tone
presentation.
After testing, freezing behavior (i.e., immobility except for
breathing) was scored via EVENTLOG software (designed by
Robert Henderson in 1986) by a trained observer blind to the
animals’ treatments.
WATER CROSS MAZE
WCM training was performed using the hippocampus-dependent
place learning protocol (Kleinknecht et al., 2012). In brief, the
WCM consisted of four arms termed N, E, S, W made of trans-
parent Plexiglas. It was filled with water (22◦C ± 1◦C) up to
a height of 12 cm and contained an invisible platform of 10
cm height and 8 × 8 cm surface area at the end of either the
E or W arm. Each mouse had to perform 6 starts per day,
alternating between N and S as a starting position in a semi-
random fashion. If mice were started from N, the S arm was closed
off; if mice were started from S, the N arm was closed off, thus
turning the set-up into a functioning T-maze. For initial spatial
memory acquisition training (= week 1) the platform was always
located at the end of the W arm. In case of reversal learning
(= week 2, Experiment (I)) the platform was located at the
end of the E arm. Latency to reach the platform, wrong
arm entries and wrong platform visits (entering the outer
third of the arm opposite the platform containing arm) were
recorded during training and later translated to Accuracy
scores. A trial was deemed “accurate” if the animals swam
directly to the platform without entering the wrong arm or
returning to the start arm. An animal was deemed “accu-
rate” if it performed at least 5 (out of 6) accurate trials
per day (≥83.3%). The number of learners was calculated as
the percentage of accurate performers per experimental group
per day.
HISTOLOGY
Histopathological evaluation was done 37 days pi for Experiment
(I) and (II), and 11 days pi for Experiment (III) and (IV). For
Experiment (I) all animals survived the treatment (10 PBS : 10
SAVA). During Experiment (II) one SAVA-treated animal did
not survive until the end, leaving 8 PBS: 8 ucAB: 7 SAVA-
treated mice. For Experiment (III) two SAVA-treated mice and
one PBS-treated animal did not survive until the end, leaving
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13 PBS: 14 SAVA treated mice. During Experiment (IV) two
SAVA-treated animals did not survive until the end, leaving 10
PBS: 14 SAVA-treated mice.
Generally, mice were perfused with 4% paraformaldehyde
(PFA) in PBS + 0.1% glutaraldehyde (GA). Afterwards brains
were carefully dissected out, post-fixed overnight in 4% PFA-PBS
at 4◦C and subsequently stored in 30% sucrose in PBS + 0.2%
sodium azide (NaN3) at room temperature (ca. 21◦C).
Next, 30 µm-thick coronal forebrain sections were cut with
a freezing microtome resulting in a series comprising each 10th
section. The sections were collected in 0.1 M Tris-buffered saline,
pH 7.4 (TBS) containing sodium azide and were then stored
at 4◦C.
A first series of free-floating sections from all animals
was applied to the concomitant immunofluorescence label-
ing of immunoreactivities for parvalbumin (as marker for a
large subset of GABAergic neurons) and the vesicular gluta-
mate transporter (VGLUT) 1. After extensive rinsing of the
tissues with TBS, non-specific binding sites for subsequently
applied immunoreagents were blocked with 5% normal don-
key serum in TBS containing 0.3% Triton X-100 (NDS-TBS-T)
for 1 h. The sections were then incubated overnight with a mix-
ture of guinea pig-anti-parvalbumin (Synaptic Systems; 1:300 in
NDS-TBS-T) and rabbit-anti-VGLUT1 (Synaptic Systems; 1:500).
Following 3 rinses with TBS, immunoreactivities were visualized
with a mixture of carbocyanine (Cy)2-conjugated donkey-anti-
guinea pig IgG and Cy2-tagged donkey-anti-rabbit IgG (both
from Dianova, Hamburg, Germany; 20 µg/ml TBS containing 2%
bovine serum albumin = TBS-BSA) for 1 h.
For the detection of immunolesion-induced gliosis, a further
forebrain series from all mice was primarily blocked with NDS-
TBS-T for 1 h followed by incubation with a cocktail of guinea
pig-anti-glial fibrillary acidic protein (GFAP; Synaptic Systems;
1:200 in NDS-TBS-T), affinity-purified rabbit-anti-ionized cal-
cium adapter molecule 1 (Iba: Synaptic Systems; 1:400) and
biotinylated Solanum tuberosum lectin (STL; Vector, Burlingame,
CA, USA; 20 µg/ml) overnight. Rinsed sections were then
immunolabeled with Cy2- and Cy3-coupled secondary antibodies
as above, and lectin-binding sites were concomitantly revealed
with Cy5-conjugated streptavidin (Dianova; 20 µg TBS-BSA) for
1 h. Finally, all sections were extensively rinsed with TBS, briefly
washed with distilled water, mounted onto glass slides, air-dried
and coverslipped with Entellan in toluene (Merck, Darmstadt,
Germany). The omission of primary antibodies and biotinylated
STL resulted in the expected absence of immuno- and lectin-
histochemical labeling.
Pictures of immunofluorescence labeling were obtained
with a confocal laser-scanning microscope 510 Meta (Zeiss,
Oberkochen, Germany), using an argon laser (488 nm) for the
excitation of Cy2, and two helium-neon lasers exciting Cy3 (543
nm) as well as Cy5 (633 nm). These band-pass (BP) filters were
applied: BP 500–530 nm (Cy2), BP 565–615 nm (Cy3) and BP
654–718 nm (Cy5, infrared).
Semi-quantification of parvalbumin immunolabeling
For Experiment (I) the immunolabeled sections of 5 mice per
group were analyzed regarding the number of PV+ neurons in
infralimbic, prelimbic and cingulate cortex areas. For Experiment
(III) + (IV) the sections of 6 mice per group were analyzed
regarding PV+ cells for all cornu ammonis (CA) regions through-
out the dHPC. Experimental groups were compared by means
of consecutive coronal sections and PV+ neurons were pooled
bilaterally per animal.
Picture acquisition was performed using a Keyence microscope
BZ-9000 (Düsseldorf, Germany) and associated software. Statis-
tical analysis of the collected data was carried out as described
below.
STATISTICAL ANALYSES
Behavioral and histological datasets were obtained blind to the
treatment of the animals. They were analyzed by means of
parametric (t-test or ANOVA followed by Tukey HSD post-hoc
test given significant factorial interactions) or distribution (chi2)
statistics using SPSS (IBM SPSS Statistics; New York, USA),
STATISTICA for Windows (V 5.0 StatSoft, Inc., Tulsa, OK, USA;
1995) and GraphPad Prism™(version 5.0; GraphPad Software
Inc.; San Diego, CA, USA). Results were considered significant if
p < 0.05. All results were plotted with GraphPad Prism™(version
5.0; GraphPad Software Inc.; San Diego, CA, USA) as mean ±
standard error of mean (Mean± SEM).
RESULTS
EXPERIMENT (I)—BEHAVIORAL AND HISTOPATHOLOGICAL
CONSEQUENCES OF LONG-TERM GABAERGIC DEPLETION IN
PRELIMBIC CORTEX
Experiment (I) analyzed the effects of GABAergic depletion in
the PrL (Figures 1A,B). SAVA administration did not affect
the Distance traveled in the OF (Figure 1C1) but decreased
both rearing frequency and rearing duration (Figures 1C2,3; RF:
treatment × time: F(5,90) = 5.67, p = 0.00014 and RD: F(5,90)
= 3.24, p = 0.0098). Furthermore, SAVA treatment caused a
trend towards a decreased latency for entering the light com-
partment of the D-L box (i.e., slight decrease in anxiety related
behavior; Figure 1D1; p = 0.08), without altering the fre-
quency to enter the light compartment or the time spent in it
(Figures 1D2,3). SAVA-treated mice showed unaffected acous-
tic startle-input/output responses (ASR-I/O; Figure 1E1), but
displayed decreased pre-pulse facilitation (PPF) for pre-pulse
intensities of 55 dB and 65 dB, but not 75 dB (Figures 1E2–4;
55 dB: treatment × inter-pulse interval: F(4,72) = 5.36,
p = 0.00078; 65 dB: treatment× inter-pulse interval: F(4,72) = 8.02,
p < 0.0001).
Regarding WCM performance, SAVA-treated mice did
not show any differences during week 1 of training (i.e.,
acquisition; Figures 1F1–4), but revealed a decreased
accuracy during week 2 (i.e., reversal learning; Figure 1F3;
treatment × day: F(6,108) = 2.73, p = 0.017). These treatment
effects were also mirrored at the population level when comparing
the number of accurate learners at the last day of each week
(Figure 1F4; chi2 week 1 day 7: p = 0.5312; chi2 week 2 day 7:
p = 0.025).
SAVA treatment resulted in a trend towards reduced contextual
fear memory 24 h after shock application (Figures 1G1,2; p =
0.07) and a more rapid decrease in their freezing response over
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FIGURE 1 | Experiment I—behavioral consequences of long-term
GABAergic depletion in prelimbic cortex (PrL): (A) timeline for
Experiment I: stereotaxic PBS or SAVA injection at d0, recovery for 14 days,
basal phenotyping (OF, D-L Box, ASR (I/O, PPI/PPF)) d15 to 21 post injection;
cognitive testing (WCM, FC) d22 to 36 pi. Brains were collected after
transcardial perfusion on d37. (B) Injection sites for Exp. I: PrL, bilateral, 0.5 µl
each side (l 0.5; a-p +1.9; v 2.5 mm from Bregma); groups and sample size for
Experiment I; (C1–3) OF behavior; (D1–3) D-L behavior (E1–4) ASR as basic
Input/Output curve and PPI/PPF curves after a 55, 65, 75 dB pre-pulse,
respectively, for 5 different IPIs; (F1) basic schema of WCM; (F2–4) learning
parameters for WCM; (G1) timeline for FC: tone-shock pairing on d0; testing
(Continued )
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FIGURE 1 | Continued
for contextual and tone memory in conditioning and novel context on d1;
(G2) comparison of contextual memory in the different contexts with and
without tone presentation presented as freezing behavior over the course
of 3 min observation periods (%); (G3) tone memory presented as freezing
behavior (%) in novel context before and after presentation of tone. All data
presented as mean ± SEM; ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001 (Student’s
t-test, chi2 test or ANOVA followed by Tukey HSD post hoc test). ASR =
acoustic startle response; dB SPL = decibel sound pressure level; D-L =
dark-light box; FC = fear conditioning; I/O = input/output; IPI = inter pulse
interval; OF = open field; pi = post injection; PBS = phosphate-buffered
saline; PPI/PPF = pre-pulse inhibition/facilitation; WCM = water cross maze.
the course of the 3-min re-exposure to the conditioned tone
(Figure 1G3; treatment× time: F(10,180) = 2.09, p = 0.027).
Histopathological analyses (Figures 6A1–6) revealed a
significantly decreased number of PV+ cells in the PrL
(p = 0.0294; Figure 6A6) and anterior cingulate cortex
(p = 0.0408; Figure 6A5) of SAVA treated animals. While
we observed some loss of PV+ cells in the infralimbic cortex
of SAVA-treated mice, the difference failed to reach statistical
significance (data not shown; p = 0.21) and thus points to a
limited dorso-ventral spread of GABAergic depletion.
EXPERIMENT (II)—BEHAVIORAL AND HISTOPATHOLOGICAL
CONSEQUENCES OF LONG-TERM GABAERGIC DEPLETION IN THE
DORSAL HIPPOCAMPUS
Experiment (II) investigated the behavioral effects of GABAer-
gic interneuron ablation via SAVA immunotoxin in the dHPC
(Figures 2A,B). GABAergic neuronal loss in the dorsal HPC
increased the distance traveled in the OF for the last 10 min
of testing (Figure 2C1; treatment × time: F(10,100) = 3.63, p
= 0.0004). However, loss of GABAergic neurons in the dHPC
had diverging effects on rearing behavior. Rearing frequency was
not affected by immuno-lesioning (Figure 2C2), but the rearing
duration was significantly decreased in SAVA-treated animals
(Figure 2C3; treatment effect: F(2,20) = 4.09, p = 0.0323). In
contrast, anxiety-related behavior in the D-L (Figures 2D1–3),
ASR-I/O (Figure 2E1) and PPI/PPF (Figures 2E2–4) were all
unaffected by GABAergic neuronal loss in the dHPC.
When tested for spatial place learning abilities in the WCM
(Figure 2F1), SAVA-treated mice showed marked impairments for
all learning parameters (Figures 2F2–4): SAVA-treated animals
displayed a higher latency to reach the platform (Figure 2F2;
treatment× day: F(8,80) = 5.12, p< 0.0001), and were less accurate
in their performance (Figure 2F3; treatment× day: F(8,80) = 7.46,
p < 0.0001), which again also became evident at the population
level when comparing the number of accurate learners between
treatment groups at the end of training (Figure 2F4; chi2 day 5:
p < 0.0001). Since none of the SAVA-treated animals had learned
the location of the platform at the end of training, we refrained
from assessing reversal-learning abilities.
Lastly, SAVA treatment of the dHPC failed to significantly
affect contextual and auditory cued fear memory 24 h after shock
application (Figures 2G1–3).
Histopathological analyses revealed a complete absence of
PV+ from the dHPC (Figures 6B3,4; due to massive cellular
loss statistics not applicable). However, despite precise injection
locations SAVA-induced GABAergic lesions spread beyond the
confines of the hippocampal formation, in particular affecting the
posterior parietal cortex dorsal to the injection site.
EXPERIMENT (III)—BEHAVIORAL CONSEQUENCES OF SHORT-TERM
GABAERGIC DEPLETION IN DORSAL HIPPOCAMPUS; FOCUS ON
SPATIAL MEMORY ACQUISITION
Given the massive cell-loss throughout the dHPC 37 days after
SAVA application Experiment (III) investigated the short-term
effects and thus the specificity of the effects following GABAergic
depletion in the dHPC, with a particular focus on the acquisition
of a spatial memory (Figures 3A,B). SAVA treatment did not
affect the distance traveled nor the rearing behavior in the OF
two days after its administration (Figures 3C1–3). However, ten
days pi SAVA-treated animals displayed a drastically heightened
distance traveled in the OF (Figures 3E1,2; Distance d2 pi vs. d10
pi treatment× day: F(1,25) = 31.1914, p< 0.0001; Distance d10 pi
treatment effect: F(1,25) = 17.15, p = 0.0003) but still no changes
in rearing behavior (Figures 3E3,4). Furthermore, WCM training
beginning three days after SAVA administration (Figure 3D1)
revealed a severe learning impairment for SAVA-treated animals
across all learning parameters (Figures 3D2–4): SAVA-treated
mice displayed a longer latency to reach the platform (Figure 3D2;
treatment× day: F(6,150) = 8.28, p< 0.0001), a decreased accuracy
to swim directly to the platform (Figure 3D3; treatment × day:
F(6,150) = 7.63, p < 0.0001) and a reduced number of accurate
performers at the end of training (i.e., Learners, Figure 3D4; chi2
day 7: p = 0.0012).
Histopathological analyses of Experiment III (Figures 6C1–5)
revealed a vastly reduced number of PV+ cells in the CA regions
of the dHPC in SAVA-treated animals (p < 0.0001; Figure 6C5),
which once again additionally affected cortical regions.
EXPERIMENT (IV)—BEHAVIORAL CONSEQUENCES OF SHORT-TERM
GABAERGIC DEPLETION IN DORSAL HIPPOCAMPUS; FOCUS ON
SPATIAL MEMORY RECALL
In order to determine whether GABAergic neuronal loss in the
dHPC causes a general cognitive impairment or whether the
observed effects were specific to the acquisition of a spatial
memory, Experiment (IV) investigated the short-term conse-
quences of GABAergic neuronal loss in the dHPC with par-
ticular focus on the recall of a spatial memory. Therefore,
animals were equipped with guide cannulas aimed at the
dHPC (similar to Experiment (III)), but were first trained in
the spatial learning paradigm of the WCM until all of them
had reached the accuracy criterion (Figures 4D1–4; Training
day 1–7). Subsequently, animals were injected with SAVA or PBS
and then repeatedly tested in OF and WCM (Figures 4A,B).
Similar to Experiment (III), SAVA treatment did not affect OF
behavior on day 2 pi (Figures 4C1–3), but resulted in a signif-
icantly increased distance traveled on day 8 pi (Figures 4E1,2;
Distance d2 pi vs. d8 pi treatment × day: F(1,22) = 10.1958,
p = 0.0042; d8 Distance treatment × time: F(5,110) = 4.53,
p = 0.0009) as well as a significantly increased rearing frequency
(Figure 4E3; treatment effect F(1,22) = 5.62, p = 0.027), but
no changes in rearing duration (Figure 4E4). Re-testing in the
WCM on day 3 + 4 pi revealed a treatment-dependent trend
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FIGURE 2 | Experiment II—behavioral consequences of long-term
GABAergic depletion in dorsal hippocampus (dHPC): (A) timeline for
Experiment II: stereotaxic PBS, ucAB or SAVA injection at d0, recovery for
14 days, basal phenotyping (OF, D-L Box, ASR (I/O, PPI/PPF)) d15 to 21 post
injection; cognitive testing (WCM, FC) d22 to 36 post injection. Brains were
collected after transcardial perfusion on d37. (B) Injection sites for
Experiment II: dHPC, bilateral, 2µl each side (l 1.3; a-p −1.8; v 2.0 mm from
Bregma); groups and sample size for Experiment II; (C1–3) OF behavior;
(D1–3) D-L Box behavior; (E1–4) ASR as basic Input/Output curve and
PPI/PPF after a 55, 65, 75 dB pre-pulse, respectively, for 5 different IPIs; (F1)
basic schema of WCM; (F2–4) learning parameters for WCM; (G1) timeline
for FC: tone-shock pairing on d0; testing for contextual and tone memory in
conditioning and novel context on d1;
(Continued )
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FIGURE 2 | Continued
(G2) comparison of contextual memory in the different contexts with and
without tone presentation presented as freezing behavior over the course
of 3 min observation periods (%); (G3) tone memory presented as freezing
behavior (%) in novel context before and after presentation of tone. All data
presented as mean ± SEM; ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001 (chi2 test or
ANOVA followed by Tukey HSD post hoc test; ucAB = unconjugated
antibody; other abbreviations as in Figure 1).
towards an increased latency (F(1,22) = 4.08, p = 0.056) but no
accuracy differences between groups (Figures 4D2,3). However,
although not statistically significant, the number of learners in
the PBS-treated groups increased from d3 to d4 pi (from 60%
to 80%), whereas it decreased for SAVA-treated animals (from
64% to 50%). Re-testing on day 9 + 10 pi in turn, revealed
a significant treatment effect on latency (F(1,22) = 15.21, p =
0.0008) but only a treatment-dependent trend for performance
accuracy (F(1,22) = 3.55, p = 0.073). The number of learners per
treatment group was nearly identical day 9 pi (PBS: 70%; SAVA:
64%; chi2 day 9 pi: p = 0.77), but again differed significantly on
day 10 pi (PBS: 100%; SAVA: 64%; chi2 day 10 pi: p = 0.034;
Figure 4D4).
Thus, initial recall performance was nearly identical for SAVA-
and PBS treated mice at multiple testing time points pi. However,
if the first recall day was followed by another day of training, PBS-
treated animals improved once again in accuracy levels and num-
ber of accurate learners, whereas SAVA-treated animals stagnated
or even decreased in WCM performance during re-acquisition,
thereby replicating our findings of Experiment (III) regarding
the (re-) acquisition-abilities of a spatial memory after GABAergic
depletion in the dHPC.
Histopathological analyses (Figures 6D1–5) revealed a signif-
icantly reduced number of PV+ cells in the CA regions of the
dHPC for SAVA-treated animals (p = 0.019; Figure 6D5). Similar
to Experiment III SAVA-induced GABAergic lesions again also
pertained to cortical structures close to the injection site.
EXPERIMENT (V)—MUSCIMOL–CONTROL
In order to demonstrate that the dHPC itself is involved in
the recall of a spatial memory, a separate cohort of mice was
equipped with guide cannulas aimed at the dHPC and then
trained in the WCM (Figures 5A–D) until all of them had
reached the accuracy criterion (d7, Figures 5C,D). One day
later later mice were injected with muscimol (MSC; GABAA
agonist) into the dHPC, and 10 min thereafter their perfor-
mance in the WCM was assessed. MSC injection resulted in a
severely impaired WCM performance (Accuracy d7 vs. MSC:
p = 0.0005; Learners d7 vs. MSC: p = 0.0001, chi2 test).
Another 24 h later, following treatment with PBS, WCM per-
formance was recovered (Figures 5C,D; Accuracy d7 vs. PBS:
p = 0.1970; Learners d7 vs. PBS: p = 0.2794, chi2 test; Learners
MSC vs. PBS: p = 0.0195, chi2 test). Thus, the dHPC is involved in
the process of recalling a previously acquired memory; however,
based on the results of Experiment (IV), GABAergic interneurons
of the dHPC are not necessary for this process.
In summary, we were able to demonstrate that (1) deple-
tion of GABAergic neurons in the PrL (Experiment (I))
results in decreased PPF (i.e., altered sensorimotor gating) and
impairments in reversal learning (i.e., cognitive dysfunction),
both of which are symptomatic hallmarks of schizophrenia
and are widely replicated in animal models of this disease.
Furthermore, we could show that depletion of GABAergic neu-
rons from the dHPC causes (2) alterations in OF behavior (i.e.,
hyperlocomotion), the specificity and extent of which are depen-
dent on the time point of testing in relation to SAVA treatment
(Experiment (II), (III) + (IV)). In addition, we found that deple-
tion of GABAergic neurons in the dHPC (3) impairs spatial mem-
ory acquisition (Experiment (II)). Moreover, we also observed
a marked impairment in spatial learning abilities shortly after
(i.e., 3 days) SAVA treatment (Experiment (III)), although injec-
tion volume as well as incubation period were drastically reduced
compared to (III), thus underlining the essential function of
GABAergic hippocampal neurons for the acquisition of a spatial
memory. In contrast, we found that (4) hippocampal GABAergic
depletion does not affect the re-call performance of a previously
acquired spatial memory (Experiment (IV)), implicating distinct
GABAergic functions regarding the acquisition and the recall of a
spatial memory.
DISCUSSION
Given the importance of GABAergic interneurons throughout the
CNS and their often proposed major involvement in the dis-
ease etiology and progression of schizophrenia, this study aimed
to further elucidate the behavioral consequences of GABAergic
depletion in the PrL and the dHPC with regard to schizophrenia-
related symptoms such as hyperlocomotion, altered sensorimotor
gating and cognitive dysfunction.
We employed SAVA in order to deplete either the PrL or
the dHPC from GABAergic interneurons (Antonucci et al.,
2012). We confirmed the efficacy of the intervention by
immunolabeling of PV+ neurons, which represent a large
and important class of GABAergic interneurons (Celio, 1986;
Caillard et al., 2000; Markram et al., 2004; Kubota, 2014)
and have been previously implicated in schizophrenia-related
disease etiology and symptom development (Gill and Grace,
2014).
Our data show that injection of the immunotoxin SAVA into
the PFC did not affect the acquisition of a spatial memory,
but selectively interfered with reversal learning (i.e., cognitive
flexibility) and PPF of the ASR (i.e., sensorimotor gating).
In contrast, SAVA injection into the dHPC severely impaired
the acquisition of a spatial memory, independent of injection
volume or incubation period. Strikingly, hippocampal SAVA
treatment after memory acquisition failed to significantly affect
the recall of a spatial memory. Furthermore, an incubation
period of 10 days resulted in a markedly hyperactive pheno-
type, which was attenuated at later time points. In summary,
SAVA treatment generates schizophrenia related positive symp-
toms (i.e., hyperlocomotion; deficits in sensorimotor gating)
as well as cognitive deficits. The specificity of these effects is
dependent on the target site and the duration of GABAergic
depletion.
Although we were able to induce distinct and striking behav-
ioral alterations with this approach, GABAergic depletion via
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FIGURE 3 | Experiment III—behavioral consequences of short-term
GABAergic depletion in dorsal hippocampus (dHPC)—acquisition:
(A) timeline for Experiment III: stereotaxic cannula implantation at d0,
recovery for 12 days, SAVA application = d0 pi; OF testing d2 pi + d10 pi,
WCM training d3 pi until d9 pi, harvesting of brains after transcardial
perfusion on d11 pi; (B) cannula position for SAVA III: dHPC, bilateral, l 1.3;
a-p −1.8; v 1.0 mm from Bregma; injection of 0.5 µl PBS or SAVA per cannula;
groups and sample size; (C1–3) OF behavior d2 pi; (D1) basic schema of
WCM; (D2–4) learning parameters in the WCM; (E1) OF Distance d2 pi vs.
d10 pi; (E2–4) OF behavior d10 pi All data presented as mean ± SEM;
∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001 (Student’s t-test, chi2 test or ANOVA
followed by Tukey HSD post hoc test; abbreviations as in Figure 1).
SAVA injection has methodological limitations. For instance the
hypothesized specificity, in particular regarding the injections
in the PrL, could not be achieved. Rather, SAVA injection in
the PrL resulted in GABAergic depletion throughout the medial
prefrontal cortex (mPFC; cf Figure 6A). Furthermore, we cannot
exclude that the observed phenotype after SAVA administration
in Experiment (I) and (II) result from a cascade of neu-
rodegenerative processes initiated by the selective lesioning of
GABAergic neurons (Antonucci et al., 2012). However, such a
cascade of secondary mechanisms and thus a steady increase
in pathological severity are in fact hallmarks of many neuro-
logical disorders and our data might therefore indeed represent
consequences of a pathological disease state. In fact, several
recent publications have pointed out the neurodegenerative-like
mechanisms observed for schizophrenic patients, in particular
regarding abnormal gliosis (Black et al., 2004; Dwork et al., 2007;
Pino et al., 2014) and have even linked schizophrenia to accel-
erated aging (Tang et al., 2009; Anthes, 2014). Therefore, while
our approach might not allow us to specifically analyze the con-
sequences of a purely GABAergic depletion, it effectively mimics
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FIGURE 4 | Experiment IV—behavioral consequences of short-term
GABAergic depletion in dorsal hippocampus (dHPC)—recall :
(A) timeline for Experiment IV: stereotaxic cannula implantation at d0,
recovery for 12 days, OF testing on d13, WCM training d14–20, SAVA
application = d0 pi, OF testing d2 pi + d8 pi, WCM recall-training d3 +
4 pi and d9 + 10 pi, harvesting of brains after transcardial perfusion on
d11 pi; (B) cannula position for SAVA IV: dHPC, bilateral, l 1.3; a-p −1.8;
v 1.0 mm from Bregma; injection of 0.5 µl PBS or SAVA per cannula;
groups and sample size; (C1–3) OF behavior d2 pi; (D1) basic schema
of WCM; (D2–4) learning parameters in the WCM; (E1) OF Distance
d2 pi vs. d10 pi; (E2–4) OF behavior d8 pi All data presented as mean
± SEM; ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001 (Student’s t-test, chi2 test
or ANOVA followed by Tukey post hoc test; abbreviations as in
Figure 1).
a pathological state such as e.g., present in schizophrenic patients.
Consequently, our work support a differential involvement of
both HPC and PFC malfunction in schizophrenia as well as
the time dependent symptom development following GABAergic
manipulations.
There are several subclasses of GABAergic interneurons, which
have been proposed to be differentially involved in generating
a behavioral phenotype (Lewis, 2000; Markram et al., 2004;
Kubota, 2014), however, our approach of SAVA injections does
not allow for a distinction regarding their specific involvement
in the observed behavioral effects. In order to determine the
overall extent of the relative GABAergic neuronal loss for each
target area, we chose to visualize parvalbumin containing (PV+)
neurons, as they represent one of the largest subclasses of
GABAergic interneurons and have been previously implicated in
learning and memory-related processes (Caillard et al., 2000).
Indeed, we observed significant PV+ loss after every SAVA injec-
tion. Nonetheless, given the strong and opposing effects after
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FIGURE 5 | Experiment V: Muscimol–Control: (A) timeline for
Experiment V: stereotaxic cannula implantation at d0, recovery for 12 days,
WCM training d13–19, Muscimol treatment and WCM recall d20, PBS
Treatment and WCM recall d21; (B) Cannula position for muscimol/PBS
injections: dHPC, bilateral, l 1.3; a-p −1.8; v 1.0 mm from Bregma; injection
of 0.5 µl MSC (125 µg/µl) or PBS per hemisphere; (C) basic schema of
WCM; (D1 + D2) learning parameters for WCM. Data presented as mean ±
SEM; ∗∗∗p < 0.001 (chi2 test or paired Student’s t-test). dHPC = dorsal
hippocampus; MSC = muscimol; PBS = phosphate-buffered saline.
short-term SAVA incubation in the dHPC (i.e., memory acqui-
sition vs. memory recall); we can conclude that SAVA injections
distinctly affect the functionality of a local neuronal network and
thus result in discreet behavioral alterations due to GABAergic
depletion.
Remarkably, SAVA administration into the PrL/mPFC specifi-
cally affected PPF, but not PPI of the startle response. Most studies
in animal models of schizophrenia employ IPI of ≥25 ms and,
thus miss potential changes in PPF (Swerdlow and Geyer, 1998;
Geyer et al., 2002; Plappert et al., 2004). In addition, ASRs with or
without a given pre-pulse are not merely dependent on a possible
pathology, but also on the genetic background of the employed
animals as well as on the set-up itself (Paylor and Crawley, 1997;
Plappert et al., 2004). Thus, the observed alterations in PPF,
but not PPI, might result from a literal left-shift of the IPI-
response curve. Alternatively the drastic interference of extensive
GABAergic depletion in the mPFC via SAVA injection could also
have revealed a novel sensorimotor-gating effect and therefore a
bona fide PPF effect.
Previous work has implicated the mPFC and in particular
the PrL in the expression of a fear response and has shown
that decreased PrL activity resulted in decreased fear responses
(Corcoran and Quirk, 2007; Piantadosi and Floresco, 2014).
However, it has also been recently proposed that prelimbic and
infralimbic areas of the mPFC exert opposing functions, with
increased IL activity decreasing fear responses (Vidal-Gonzalez
et al., 2006; Van De Werd et al., 2010; Ashwell and Ito, 2014).
As mentioned above, our SAVA injections were not as specific to
the PrL as originally hypothesized. Thus, IL GABAergic depletion
could have resulted in increased IL excitatory output which would
decrease amygdala output and result in decreased fear responses,
which in turn could account for the observed accelerated decline
in fear response to the auditory conditioned stimulus after SAVA
application to the mPFC. Alternatively, we cannot entirely rule
out that the reduced freezing response results from secondary
loss of glutamatergic neurons of the PrL in consequence of the
primary GABAergic lesion (Antonucci et al., 2012).
Different types of GABAergic neurons are known for their
involvement in spatial learning (McNamara and Skeleton, 1993;
Miettinen et al., 1993; Brucato et al., 1996; Iijima et al., 1996;
Moser and Moser, 1998; Paulsen and Moser, 1998; Zilles et al.,
2000; Bannerman et al., 2004; Ruediger et al., 2011; Buetfering
et al., 2014). Our findings of intact acquisition but impaired rever-
sal learning abilities following SAVA injection into the mPFC are
concordant with the prominent role regarding cognitive flexibility
ascribed to this brain structure (Euston et al., 2012). Correspond-
ingly, the impairment of spatial learning abilities following SAVA
injection into the dHPC is in line with our previous findings
obtained by excitotoxic lesions of the hippocampus (Kleinknecht
et al., 2012) as well as other works (Ruediger et al., 2011;
Gilani et al., 2014). Nonetheless, we have to concede that the
SAVA-induced GABAergic lesions were not entirely exclusive to
the hippocampal formation and additionally pertained to cor-
tical areas in close proximity to the injection site. In particular
GABAergic loss and thus a malfunction of the posterior parietal
cortex may have contributed to the deficits in spatial learning
as observed in the present study (Harvey et al., 2012; Katsuki
and Constantinidis, 2012; Myskiw and Izquierdo, 2012; Whitlock
et al., 2012).
The importance of hilar interneurons for both the acquisition
and the recall of a spatial memory has been previously reported
(Andrews-Zwilling et al., 2012). However, our data provide first
evidence for a distinction in the impact of GABAergic neurons
beyond the hilar region on memory acquisition vs. memory recall.
While SAVA-treatment three days before training in the WCM
severely impaired spatial learning abilities, SAVA application in
well-trained animals three days before the recall of a spatial mem-
ory failed to significantly impair the recall abilities. We controlled
for a possibly transient involvement of the dHPC in the recall of
spatial memories by treating a different cohort of mice with the
GABAA receptor agonist muscimol immediately before recall of
spatial memory. Thus, we can conclude that although the dHPC is
necessary for the recall of a previously learned platform position
in the WCM, GABAergic neurons appear to be non-essential in
this context.
In addition to the cognitive effects after SAVA admin-
istration at the level of the dHPC, we also observed a
duration-dependent hyperlocomotor phenotype in these mice.
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FIGURE 6 | Histology Experiment I through IV: (A1 + 2–D1 + 2)
respective location and extension of lesions for Experiment I–IV; (A1–D1)
lesion extent: black = smallest occurring lesion, gray = biggest occurring
lesion; (A3) representative image of prelimbic region of PBS-treated
mouse; (A4) representative image of prelimbic region of SAVA-treated
mouse; (A5 + 6) quantification of parvalbumin positive cells (PV+) in
anterior cingulate cortex and prelimbic cortex, respectively;
(B3) representative image of CA1 region of PBS-treated mouse;
(B4) representative image of CA1 region of SAVA-treated mouse;
(C3) representative image of CA1 region of PBS-treated mouse; (C4)
representative image of CA1 region of SAVA-treated mouse; (C5)
quantification of PV+ cells for Experiment III for all CA sub-regions; (D3)
representative image of left dHPC of PBS-treated mouse; (D4)
representative image of left dHPC of SAVA-treated mouse; (D5)
quantification of PV+ cells for Experiment IV for all CA sub-regions;
stainings: green = PV+; red = VGLUT1; Data presented as mean ± SEM;
∗p < 0.05, ∗∗∗p < 0.001 (Student’s t-test). CA = cornu ammonis;
PBS = phosphate-buffered saline; PV = parvalbumin.
An increased locomotor activity after the reduction of PV+ neu-
rons in the dHPC has previously been reported in the context of
rodent models for schizophrenia (Penschuck et al., 2006).
Given the shortened time-span between SAVA administra-
tion and behavioral assessment for Experiment III and IV,
we concluded that the observed behavioral effects are most
likely largely mediated by the GABAergic depletion in the dHPC
itself and are representative of the early stages of the previously
mentioned neurodegeneration-related cascade. However, aside
from the consequences of SAVA administration on GABAergic
interneurons, we also had to consider consequences of inflam-
mation due to the injection/cannula implantation itself, as well
as long-term consequences of GABAergic neuronal loss. It has
been shown before that disrupting the integrity of skull and
brain as a whole (e.g., via surgery) induces an inflammatory
response (reviewed in e.g., Wang and Shuaib, 2002), which in
turn can cause astrocytosis (Eng et al., 1992). An increased
inflammatory response could also lead to alterations in behavior
(Dantzer et al., 2008), and we did observe an increase in microglia
activity in SAVA-treated animals compared to PBS treated animals
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(data not shown but previously published in (Antonucci et al.,
2012)). However, the observed behavioral effects, in particular
for experiments affecting the hippocampus, are so severe (i.e.,
ablation of spatial learning abilities) and also very specific to
the time point of injection (acquisition vs. recall), that they are
most likely not primarily based on an increased inflammatory
response. This holds true in particular for SAVA-treated animals
tested in Experiment (III + IV). The animals in (III) displayed
severe place learning impairments already on day five after SAVA
administration, whereas animals in (IV) showed no effect on
recall memory but a strong effect on locomotor activity.
Regarding long-term consequences of immunotoxin-induced
loss of GABAergic neurons, Antonucci et al. (2012) previously
reported a loss of CA1 pyramidal neurons 12 days after SAVA
treatment. Since basal phenotyping for Experiment (I) + (II)
only started on day 15 after SAVA administration, we cannot
exclude that non-GABAergic neuronal populations were also
successively affected and contributed to the observed phenotypes.
However, Experiment (III) + (IV) resulted in clear and distinctive
behavioral effects within 10 days of SAVA administration, which
indicate a predominantly GABAergic driven effect (Antonucci
et al., 2012). Furthermore, in terms of compensatory mechanisms,
a reduction, albeit delayed, of excitatory neurons might in fact be
beneficial for a functioning local neuronal network, particularly
in the hippocampus, since inhibitory interneuron loss can lead
to epileptiform seizures in animal models as well as in humans
(de Lanerolle et al., 1989).
In conclusion, we demonstrated that GABAergic lesions result
in distinct behavioral phenotypes specific to the target site and
modulated by incubation time. We underlined the involvement of
the medial prefrontal area in schizophrenia-like symptom devel-
opment (sensorimotor-gating deficits and cognitive flexibility)
and highlight a functional distinction of GABAergic neurons in
the dHPC regarding spatial memory acquisition and memory
recall: GABAergic neurons are necessary for the acquisition of a
new spatial memory, but not for the recall.
While our approach did not enable us to distinguish discrete
GABAergic neuronal circuits, we were able to simulate a patholog-
ical disease state and the consequences of prolonged GABAergic
depletion. Therefore, our data provide new insights into behav-
ioral alterations following GABAergic depletion, and in particular
regarding the role of GABAergic neurons in the generation of
positive schizophrenia-like symptoms such as hyperlocomotion
and altered sensorimotor gating as well as the origin of cognitive
deficits.
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